161 related articles for article (PubMed ID: 1846190)
1. Stable antiviral expression in BALB/c 3T3 cells carrying a beta interferon sequence behind a major histocompatibility complex promoter fragment.
Seif I; De Maeyer E; Riviere I; De Maeyer-Guignard J
J Virol; 1991 Feb; 65(2):664-71. PubMed ID: 1846190
[TBL] [Abstract][Full Text] [Related]
2. Enhanced resistance to HIV-1 replication in U937 cells stably transfected with the human IFN-beta gene behind an MHC promoter fragment.
Mace K; Seif I; Anjard C; De Maeyer-Guignard J; Dodon MD; Gazzolo L; De Maeyer E
J Immunol; 1991 Nov; 147(10):3553-9. PubMed ID: 1940355
[TBL] [Abstract][Full Text] [Related]
3. Development of methods for somatic cell gene therapy directed against viral diseases, using retroviral vectors carrying the murine or human interferon-beta coding sequence: establishment of the antiviral state in human cells.
Lauret E; Riviere I; Rousseau V; Vieillard V; De Maeyer-Guignard J; De Maeyer E
Hum Gene Ther; 1993 Oct; 4(5):567-77. PubMed ID: 8280795
[TBL] [Abstract][Full Text] [Related]
4. Blocking of retroviral infection at a step prior to reverse transcription in cells transformed to constitutively express interferon beta.
Vieillard V; Lauret E; Rousseau V; De Maeyer E
Proc Natl Acad Sci U S A; 1994 Mar; 91(7):2689-93. PubMed ID: 7511818
[TBL] [Abstract][Full Text] [Related]
5. Autocrine interferon-beta synthesis for gene therapy of HIV infection: increased resistance to HIV-1 in lymphocytes from healthy and HIV-infected individuals.
Vieillard V; Lauret E; Maguer V; Jacomet C; Rozenbaum W; Gazzolo L; De Maeyer E
AIDS; 1995 Nov; 9(11):1221-8. PubMed ID: 8561974
[TBL] [Abstract][Full Text] [Related]
6. Posttranscriptional regulation of beta interferon expression in erythroid Friend cells treated with gamma interferon.
Marziali G; Fiorucci G; Coccia EM; Percario Z; Raber J; Battistini A; Rossi GB; Affabris E; Romeo G
J Virol; 1991 Aug; 65(8):4130-6. PubMed ID: 1649320
[TBL] [Abstract][Full Text] [Related]
7. Development of recombinant vesicular stomatitis viruses that exploit defects in host defense to augment specific oncolytic activity.
Obuchi M; Fernandez M; Barber GN
J Virol; 2003 Aug; 77(16):8843-56. PubMed ID: 12885903
[TBL] [Abstract][Full Text] [Related]
8. Stable antiviral expression (SAVE) as an approach to somatic cell gene therapy directed against HIV infection.
De Maeyer E; Seif I; Vieillard V; Cases O; Rousseau V; De Maeyer-Guignard J; Lauret E
Hokkaido Igaku Zasshi; 1994 Nov; 69(6):1288-93. PubMed ID: 7705744
[TBL] [Abstract][Full Text] [Related]
9. IFN regulatory factor-1 bypasses IFN-mediated antiviral effects through viperin gene induction.
Stirnweiss A; Ksienzyk A; Klages K; Rand U; Grashoff M; Hauser H; Kröger A
J Immunol; 2010 May; 184(9):5179-85. PubMed ID: 20308629
[TBL] [Abstract][Full Text] [Related]
10. Effect of deficiency of the double-stranded RNA-dependent protein kinase, PKR, on antiviral resistance in the presence or absence of ribonuclease L: HSV-1 replication is particularly sensitive to deficiency of the major IFN-mediated enzymes.
Khabar KS; Dhalla M; Siddiqui Y; Zhou A; Al-Ahdal MN; Der SD; Silverman RH; Williams BR
J Interferon Cytokine Res; 2000 Jul; 20(7):653-9. PubMed ID: 10926208
[TBL] [Abstract][Full Text] [Related]
11. Interferon-gamma-inducible regulation of the human invariant chain gene.
Barr CL; Saunders GF
J Biol Chem; 1991 Feb; 266(6):3475-81. PubMed ID: 1899864
[TBL] [Abstract][Full Text] [Related]
12. Interferon-induced guanylate binding protein-1 (GBP-1) mediates an antiviral effect against vesicular stomatitis virus and encephalomyocarditis virus.
Anderson SL; Carton JM; Lou J; Xing L; Rubin BY
Virology; 1999 Mar; 256(1):8-14. PubMed ID: 10087221
[TBL] [Abstract][Full Text] [Related]
13. Induction of class I major histocompatibility complex antigens in human teratocarcinoma cells by interferon without induction of differentiation, growth inhibition, or resistance to viral infection.
Andrews PW; Trinchieri G; Perussia B; Baglioni C
Cancer Res; 1987 Feb; 47(3):740-6. PubMed ID: 3026615
[TBL] [Abstract][Full Text] [Related]
14. Susceptibility to virus infection is determined by a Stat-mediated response to the autocrine effect of virus-induced type I interferon.
Improta T; Pine R
Cytokine; 1997 Jun; 9(6):383-93. PubMed ID: 9199872
[TBL] [Abstract][Full Text] [Related]
15. Studies on the role of the 2'-5'-oligoadenylate synthetase-RNase L pathway in beta interferon-mediated inhibition of encephalomyocarditis virus replication.
Kumar R; Choubey D; Lengyel P; Sen GC
J Virol; 1988 Sep; 62(9):3175-81. PubMed ID: 2841470
[TBL] [Abstract][Full Text] [Related]
16. A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes.
Ory DS; Neugeboren BA; Mulligan RC
Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11400-6. PubMed ID: 8876147
[TBL] [Abstract][Full Text] [Related]
17. Mouse peritoneal cells confer an antiviral state on mouse cell monolayers: role of interferon.
Proietti E; Gessani S; Belardelli F; Gresser I
J Virol; 1986 Feb; 57(2):456-63. PubMed ID: 3003378
[TBL] [Abstract][Full Text] [Related]
18. Studies on interferon-sensitive cells derived from the interferon-resistant NIH 3T3 clone 1 line.
Mittnacht S; Jacobsen H
Prog Clin Biol Res; 1985; 202():237-45. PubMed ID: 2421304
[TBL] [Abstract][Full Text] [Related]
19. Regulation of macrophage growth and antiviral activity by interferon-gamma.
Goldberg M; Belkowski LS; Bloom BR
J Cell Biol; 1989 Sep; 109(3):1331-40. PubMed ID: 2549078
[TBL] [Abstract][Full Text] [Related]
20. Antiviral activity of herpes simplex virus vectors expressing murine alpha 1-interferon.
Mester JC; Pitha PM; Glorioso JC
Gene Ther; 1995 May; 2(3):187-96. PubMed ID: 7614249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
